drugset / Trial / NCT04299048
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
NaSequentialOpen-labelTreatment
Summary
Study to assess the safety and tolerability of repeated doses of an investigational new drug in patients with cancer and cachexia.
Timeline
- Start
- 2020-11-17
- Primary completion
- 2022-03-30
- Completion
- 2022-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ponsegromab | Monoclonal antibody | — | Subcutaneous |